利索-全球专利检索

  1. 登录
  2. 注册
发明申请
US20190201431A1 EX VIVO METHODS OF INDUCING IDO EXPRESSION IN ANTIGEN PRESENTING CELLS USING A COMPOUND SELECTED FROM THE GROUP CONSISTING OF AZACYTIDINE, AND DECITABINE 审中-公开

  • 专利标题： EX VIVO METHODS OF INDUCING IDO EXPRESSION IN ANTIGEN PRESENTING CELLS USING A COMPOUND SELECTED FROM THE GROUP CONSISTING OF AZACYTIDINE, AND DECITABINE
  • 申请号： US16328539
    申请日： 2017-08-25
  • 公开(公告)号： US20190201431A1
    公开(公告)日： 2019-07-04
  • 发明人: Peter ERICSSON , Hans Olov SJÖGREN
  • 申请人： IDOGEN AB
  • 申请人地址： SE Lund
  • 专利权人： IDOGEN AB
  • 当前专利权人： IDOGEN AB
  • 当前专利权人地址： SE Lund
  • 优先权： GB1614593.0 20160826; GB1709401.2 20170613
  • 国际申请： PCT/EP2017/071409 WO 20170825
  • 主分类号： A61K31/7068
  • IPC分类号： A61K31/7068 ;  A61K31/706 ;  A61K31/436 ;  A61P19/02
EX VIVO METHODS OF INDUCING IDO EXPRESSION IN ANTIGEN PRESENTING CELLS USING A COMPOUND SELECTED FROM THE GROUP CONSISTING OF AZACYTIDINE, AND DECITABINE
摘要：
The present invention relates to ex vivo methods using a compound selected from the group consisting of azacytidine, a compound of formula (I): and decitabine, a compound of formula (II): and related uses of said compounds.
信息查询
Global Dossier Espacenet
0/0